Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | APEX1 | P27695 | 1/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.51 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.51 |
| ▸ | BCHE | P06276 | 1/20 | 0.46 |
| ▸ | HPRT1 | P00492 | 1/20 | 0.45 |
| ▸ | CYP2A6 | P11509 | 4/20 | 0.44 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.43 |
| ▸ | CCR1 | P32246 | 1/20 | 0.42 |
| ▸ | CCR5 | P51681 | 1/20 | 0.42 |
| ▸ | CCR8 | P51685 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17343149 | 1.00 | CYP3A4 (0.51) | CYP3A4LMNAMAPTAPEX1MAPK1 | |
| SCHEMBL3648742 | 0.86 | CYP2A6 (0.55) | CYP3A4MAPTMAPK1BCHECYP2A6 | |
| SCHEMBL24338977 | 0.86 | CSNK2A2 (0.48) | CYP3A4LMNAMAPTAPEX1MAPK1 | |
| SCHEMBL17343151 | 0.85 | MAPT (0.46) | CYP3A4LMNAMAPTAPEX1MAPK1 | |
| SCHEMBL18201963 | 0.85 | MAPT (0.46) | CYP3A4LMNAMAPTAPEX1MAPK1 | |
| Hydrochloric Acid SCHEMBL3320131 | 0.85 | CYP2A6 (0.53) | CYP3A4MAPTMAPK1BCHECYP2A6 | |
| SCHEMBL18202028 | 0.84 | CYP3A4 (0.43) | CYP3A4LMNAMAPTAPEX1MAPK1 | |
| SCHEMBL13863592 | 0.84 | CYP3A4 (0.49) | CYP3A4LMNAMAPTAPEX1MAPK1 | |
| SCHEMBL17343655 | 0.83 | MAPT (0.44) | CYP3A4LMNAMAPTAPEX1MAPK1 | |
| SCHEMBL13863587 | 0.83 | LMNA (0.44) | CYP3A4LMNAMAPTAPEX1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230227486-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT | CANON KABUSHIKI KAISHA (JP) | 2023-07-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230227486-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT | SOD1, LEF1, ORC3 | CYP3A4 800/4885LMNA 2187/4885MAPT 3383/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.